MUC1 is abnormally up-regulated in estrogen receptor-positive breast cancer and produces tamoxifen resistance through receptor tyrosine kinases (RTK), B-catenin, and E-cadherin to mediate tumor growth control in response to tamoxifen [73]. Here, ESR1 is linked to neoplasm.